APO Research
Talk to an analyst

APO RESEARCH · REPORT

Custom Plasmid Production and Manufacturing

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Custom Plasmid Production and Manufacturing Market Outlook and Growth Opportunities 2026

5 June 2026192 pages

Choose your research edition.

Industry ResearchCustom Plasmid Production and Manufacturing Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Custom Plasmid Production and Manufacturing Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Custom Plasmid Production and Manufacturing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Custom Plasmid Production and Manufacturing Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Custom Plasmid Production and Manufacturing Market Analysis and Forecast 2026-2032259 pages · $4,950 USD

Market perspective

The global Custom Plasmid Production and Manufacturing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Custom Plasmid Production and Manufacturing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Custom Plasmid Production and Manufacturing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Custom Plasmid Production and Manufacturing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Custom Plasmid Production and Manufacturing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Custom Plasmid Production and Manufacturing market include Aldevron, Catalent Biologics, Polyplus, Creative Biogene, PlasmidFactory GmbH, Bionexus, Wuxi Advanced Therapies, Charles River Laboratories and Plasmid Biosciences, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Custom Plasmid Production and Manufacturing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Custom Plasmid Production and Manufacturing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Custom Plasmid Production and Manufacturing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Custom Plasmid Production and Manufacturing market.

Custom Plasmid Production and Manufacturing Segment by Company

Aldevron

Catalent Biologics

Polyplus

Creative Biogene

PlasmidFactory GmbH

Bionexus

Wuxi Advanced Therapies

Charles River Laboratories

Plasmid Biosciences

Sartorius AG

Porton Advanced

Oxford Genetics LTD

uBriGene

TriLink BioTechnologies

Vectorbuilder

Custom Plasmid Production and Manufacturing Segment by Type

Research Grade

Industrial Grade

GMP Grade

Others

Custom Plasmid Production and Manufacturing Segment by Application

Gene Therapy

Basic Research

Drug Development

Others

Custom Plasmid Production and Manufacturing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Custom Plasmid Production and Manufacturing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Custom Plasmid Production and Manufacturing key companies, revenue, market share, and recent developments.

3. To split the Custom Plasmid Production and Manufacturing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Custom Plasmid Production and Manufacturing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Custom Plasmid Production and Manufacturing significant trends, drivers, influence factors in global and regions.

6. To analyze Custom Plasmid Production and Manufacturing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Custom Plasmid Production and Manufacturing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Custom Plasmid Production and Manufacturing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Custom Plasmid Production and Manufacturing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Custom Plasmid Production and Manufacturing industry.

Chapter 3: Detailed analysis of Custom Plasmid Production and Manufacturing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Custom Plasmid Production and Manufacturing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Custom Plasmid Production and Manufacturing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Custom Plasmid Production and Manufacturing Industry Trends Table 2. Custom Plasmid Production and Manufacturing Industry Drivers Table 3. Custom Plasmid Production and Manufacturing Industry Opportunities and Challenges Table 4. Custom Plasmid Production and Manufacturing Industry Restraints Table 5. Global Custom Plasmid Production and Manufacturing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Custom Plasmid Production and Manufacturing Revenue Share by Company (2021-2026) Table 7. Global Custom Plasmid Production and Manufacturing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Custom Plasmid Production and Manufacturing Key Company Manufacturing Base & Headquarters Table 9. Global Custom Plasmid Production and Manufacturing Company, Product Type & Application Table 10. Global Custom Plasmid Production and Manufacturing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Custom Plasmid Production and Manufacturing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Research Grade Table 15. Significant Companies of Industrial Grade Table 16. Significant Companies of GMP Grade Table 17. Significant Companies of Others Table 18. Global Custom Plasmid Production and Manufacturing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Custom Plasmid Production and Manufacturing Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Custom Plasmid Production and Manufacturing Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Custom Plasmid Production and Manufacturing Sales Value Share by Type (2021-2026) Table 22. Global Custom Plasmid Production and Manufacturing Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Gene Therapy Table 24. Significant Companies of Basic Research Table 25. Significant Companies of Drug Development Table 26. Significant Companies of Others Table 27. Global Custom Plasmid Production and Manufacturing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Custom Plasmid Production and Manufacturing Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Custom Plasmid Production and Manufacturing Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Custom Plasmid Production and Manufacturing Sales Value Share by Application (2021-2026) Table 31. Global Custom Plasmid Production and Manufacturing Sales Value Share by Application (2027-2032) Table 32. Global Custom Plasmid Production and Manufacturing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Custom Plasmid Production and Manufacturing Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Custom Plasmid Production and Manufacturing Sales Value Share by Region (2021-2026) Table 35. Global Custom Plasmid Production and Manufacturing Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Custom Plasmid Production and Manufacturing Sales Value Share by Region (2027-2032) Table 37. Global Custom Plasmid Production and Manufacturing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Custom Plasmid Production and Manufacturing Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Custom Plasmid Production and Manufacturing Sales Value Market Share by Country (2021-2026) Table 40. Global Custom Plasmid Production and Manufacturing Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Custom Plasmid Production and Manufacturing Sales Value Market Share by Country (2027-2032) Table 42. Aldevron Company Information Table 43. Aldevron Business Overview Table 44. Aldevron Custom Plasmid Production and Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Aldevron Custom Plasmid Production and Manufacturing Product Portfolio Table 46. Aldevron Recent Development Table 47. Catalent Biologics Company Information Table 48. Catalent Biologics Business Overview Table 49. Catalent Biologics Custom Plasmid Production and Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Catalent Biologics Custom Plasmid Production and Manufacturing Product Portfolio Table 51. Catalent Biologics Recent Development Table 52. Polyplus Company Information Table 53. Polyplus Business Overview Table 54. Polyplus Custom Plasmid Production and Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Polyplus Custom Plasmid Production and Manufacturing Product Portfolio Table 56. Polyplus Recent Development Table 57. Creative Biogene Company Information Table 58. Creative Biogene Business Overview Table 59. Creative Biogene Custom Plasmid Production and Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Creative Biogene Custom Plasmid Production and Manufacturing Product Portfolio Table 61. Creative Biogene Recent Development Table 62. PlasmidFactory GmbH Company Information Table 63. PlasmidFactory GmbH Business Overview Table 64. PlasmidFactory GmbH Custom Plasmid Production and Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. PlasmidFactory GmbH Custom Plasmid Production and Manufacturing Product Portfolio Table 66. PlasmidFactory GmbH Recent Development Table 67. Bionexus Company Information Table 68. Bionexus Business Overview Table 69. Bionexus Custom Plasmid Production and Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Bionexus Custom Plasmid Production and Manufacturing Product Portfolio Table 71. Bionexus Recent Development Table 72. Wuxi Advanced Therapies Company Information Table 73. Wuxi Advanced Therapies Business Overview Table 74. Wuxi Advanced Therapies Custom Plasmid Production and Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Wuxi Advanced Therapies Custom Plasmid Production and Manufacturing Product Portfolio Table 76. Wuxi Advanced Therapies Recent Development Table 77. Charles River Laboratories Company Information Table 78. Charles River Laboratories Business Overview Table 79. Charles River Laboratories Custom Plasmid Production and Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Charles River Laboratories Custom Plasmid Production and Manufacturing Product Portfolio Table 81. Charles River Laboratories Recent Development Table 82. Plasmid Biosciences Company Information Table 83. Plasmid Biosciences Business Overview Table 84. Plasmid Biosciences Custom Plasmid Production and Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Plasmid Biosciences Custom Plasmid Production and Manufacturing Product Portfolio Table 86. Plasmid Biosciences Recent Development Table 87. Sartorius AG Company Information Table 88. Sartorius AG Business Overview Table 89. Sartorius AG Custom Plasmid Production and Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Sartorius AG Custom Plasmid Production and Manufacturing Product Portfolio Table 91. Sartorius AG Recent Development Table 92. Porton Advanced Company Information Table 93. Porton Advanced Business Overview Table 94. Porton Advanced Custom Plasmid Production and Manufacturing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Porton Advanced Custom Plasmid Production and Manufacturing Product Portfolio Table 96. Porton Advanced Recent Development Table 97. Oxford Genetics LTD Company Information Table 98. Oxford Genetics LTD Business Overview Table 99. Oxford Genetics LTD Custom Plasmid Production and Manufacturing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Oxford Genetics LTD Custom Plasmid Production and Manufacturing Product Portfolio Table 101. Oxford Genetics LTD Recent Development Table 102. uBriGene Company Information Table 103. uBriGene Business Overview Table 104. uBriGene Custom Plasmid Production and Manufacturing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. uBriGene Custom Plasmid Production and Manufacturing Product Portfolio Table 106. uBriGene Recent Development Table 107. TriLink BioTechnologies Company Information Table 108. TriLink BioTechnologies Business Overview Table 109. TriLink BioTechnologies Custom Plasmid Production and Manufacturing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. TriLink BioTechnologies Custom Plasmid Production and Manufacturing Product Portfolio Table 111. TriLink BioTechnologies Recent Development Table 112. Vectorbuilder Company Information Table 113. Vectorbuilder Business Overview Table 114. Vectorbuilder Custom Plasmid Production and Manufacturing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Vectorbuilder Custom Plasmid Production and Manufacturing Product Portfolio Table 116. Vectorbuilder Recent Development Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Custom Plasmid Production and Manufacturing Product Image Figure 2. Global Custom Plasmid Production and Manufacturing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Custom Plasmid Production and Manufacturing Market Size (2021-2032) & (US$ Million) Figure 4. Global Custom Plasmid Production and Manufacturing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Research Grade Image Figure 8. Industrial Grade Image Figure 9. GMP Grade Image Figure 10. Others Image Figure 11. Global Custom Plasmid Production and Manufacturing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Custom Plasmid Production and Manufacturing Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Custom Plasmid Production and Manufacturing Sales Value Share by Type (2021-2032) Figure 14. Gene Therapy Image Figure 15. Basic Research Image Figure 16. Drug Development Image Figure 17. Others Image Figure 18. Global Custom Plasmid Production and Manufacturing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Custom Plasmid Production and Manufacturing Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Custom Plasmid Production and Manufacturing Sales Value Share by Application (2021-2032) Figure 21. Global Custom Plasmid Production and Manufacturing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Custom Plasmid Production and Manufacturing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Custom Plasmid Production and Manufacturing Sales Value (2021-2032) & (US$ Million) Figure 24. North America Custom Plasmid Production and Manufacturing Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Custom Plasmid Production and Manufacturing Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Custom Plasmid Production and Manufacturing Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Custom Plasmid Production and Manufacturing Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Custom Plasmid Production and Manufacturing Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Custom Plasmid Production and Manufacturing Sales Value (2021-2032) & (US$ Million) Figure 30. South America Custom Plasmid Production and Manufacturing Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Custom Plasmid Production and Manufacturing Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Custom Plasmid Production and Manufacturing Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Custom Plasmid Production and Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Custom Plasmid Production and Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Custom Plasmid Production and Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Custom Plasmid Production and Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Custom Plasmid Production and Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Custom Plasmid Production and Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Custom Plasmid Production and Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Custom Plasmid Production and Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Custom Plasmid Production and Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Custom Plasmid Production and Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Custom Plasmid Production and Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Custom Plasmid Production and Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Custom Plasmid Production and Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Custom Plasmid Production and Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Custom Plasmid Production and Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Custom Plasmid Production and Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Custom Plasmid Production and Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Custom Plasmid Production and Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Custom Plasmid Production and Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Custom Plasmid Production and Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Custom Plasmid Production and Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Custom Plasmid Production and Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Custom Plasmid Production and Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Custom Plasmid Production and Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Custom Plasmid Production and Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Custom Plasmid Production and Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Custom Plasmid Production and Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Custom Plasmid Production and Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Custom Plasmid Production and Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Custom Plasmid Production and Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Custom Plasmid Production and Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Custom Plasmid Production and Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Custom Plasmid Production and Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Custom Plasmid Production and Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Custom Plasmid Production and Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Custom Plasmid Production and Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Custom Plasmid Production and Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Custom Plasmid Production and Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Custom Plasmid Production and Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Custom Plasmid Production and Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Custom Plasmid Production and Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Custom Plasmid Production and Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Custom Plasmid Production and Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Custom Plasmid Production and Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Custom Plasmid Production and Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Custom Plasmid Production and Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Custom Plasmid Production and Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Custom Plasmid Production and Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Custom Plasmid Production and Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Custom Plasmid Production and Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Custom Plasmid Production and Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Custom Plasmid Production and Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Custom Plasmid Production and Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Custom Plasmid Production and Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Custom Plasmid Production and Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Custom Plasmid Production and Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Custom Plasmid Production and Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Custom Plasmid Production and Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Custom Plasmid Production and Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Custom Plasmid Production and Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Custom Plasmid Production and Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Custom Plasmid Production and Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Custom Plasmid Production and Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Custom Plasmid Production and Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Custom Plasmid Production and Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Custom Plasmid Production and Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Custom Plasmid Production and Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Custom Plasmid Production and Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Custom Plasmid Production and Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Custom Plasmid Production and Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Custom Plasmid Production and Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Custom Plasmid Production and Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Custom Plasmid Production and Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Custom Plasmid Production and Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Custom Plasmid Production and Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Custom Plasmid Production and Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Custom Plasmid Production and Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Custom Plasmid Production and Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Custom Plasmid Production and Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Custom Plasmid Production and Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Custom Plasmid Production and Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Custom Plasmid Production and Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Custom Plasmid Production and Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Custom Plasmid Production and Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Research Grade
  • Industrial Grade
  • GMP Grade
  • Others
Applications
  • Gene Therapy
  • Basic Research
  • Drug Development
  • Others
Companies covered
  • Aldevron
  • Catalent Biologics
  • Polyplus
  • Creative Biogene
  • PlasmidFactory GmbH
  • Bionexus
  • Wuxi Advanced Therapies
  • Charles River Laboratories
  • Plasmid Biosciences
  • Sartorius AG
  • Porton Advanced
  • Oxford Genetics LTD
  • uBriGene
  • TriLink BioTechnologies
  • Vectorbuilder

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Custom Plasmid Production and Manufacturing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Custom Plasmid Production and Manufacturing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Custom Plasmid Production and Manufacturing Market Dynamics
  1. 2.1 Custom Plasmid Production and Manufacturing Industry Trends
  2. 2.2 Custom Plasmid Production and Manufacturing Industry Drivers
  3. 2.3 Custom Plasmid Production and Manufacturing Industry Opportunities and Challenges
  4. 2.4 Custom Plasmid Production and Manufacturing Industry Restraints
3 Custom Plasmid Production and Manufacturing Market by Company
  1. 3.1 Global Custom Plasmid Production and Manufacturing Company Revenue Ranking in 2025
  2. 3.2 Global Custom Plasmid Production and Manufacturing Revenue by Company (2021-2026)
  3. 3.3 Global Custom Plasmid Production and Manufacturing Company Ranking (2024-2026)
  4. 3.4 Global Custom Plasmid Production and Manufacturing Company Manufacturing Base and Headquarters
  5. 3.5 Global Custom Plasmid Production and Manufacturing Company Product Type and Application
  6. 3.6 Global Custom Plasmid Production and Manufacturing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Custom Plasmid Production and Manufacturing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Custom Plasmid Production and Manufacturing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Custom Plasmid Production and Manufacturing Market by Type
  1. 4.1 Custom Plasmid Production and Manufacturing Type Introduction
  2. 4.1.1 Research Grade
  3. 4.1.2 Industrial Grade
  4. 4.1.3 GMP Grade
  5. 4.1.4 Others
  6. 4.2 Global Custom Plasmid Production and Manufacturing Sales Value by Type
  7. 4.2.1 Global Custom Plasmid Production and Manufacturing Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Custom Plasmid Production and Manufacturing Sales Value by Type (2021-2032)
  9. 4.2.3 Global Custom Plasmid Production and Manufacturing Sales Value Share by Type (2021-2032)
5 Custom Plasmid Production and Manufacturing Market by Application
  1. 5.1 Custom Plasmid Production and Manufacturing Application Introduction
  2. 5.1.1 Gene Therapy
  3. 5.1.2 Basic Research
  4. 5.1.3 Drug Development
  5. 5.1.4 Others
  6. 5.2 Global Custom Plasmid Production and Manufacturing Sales Value by Application
  7. 5.2.1 Global Custom Plasmid Production and Manufacturing Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Custom Plasmid Production and Manufacturing Sales Value by Application (2021-2032)
  9. 5.2.3 Global Custom Plasmid Production and Manufacturing Sales Value Share by Application (2021-2032)
6 Custom Plasmid Production and Manufacturing Regional Value Analysis
  1. 6.1 Global Custom Plasmid Production and Manufacturing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Custom Plasmid Production and Manufacturing Sales Value by Region (2021-2032)
  3. 6.2.1 Global Custom Plasmid Production and Manufacturing Sales Value by Region: 2021-2026
  4. 6.2.2 Global Custom Plasmid Production and Manufacturing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Custom Plasmid Production and Manufacturing Sales Value (2021-2032)
  7. 6.3.2 North America Custom Plasmid Production and Manufacturing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Custom Plasmid Production and Manufacturing Sales Value (2021-2032)
  10. 6.4.2 Europe Custom Plasmid Production and Manufacturing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Custom Plasmid Production and Manufacturing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Custom Plasmid Production and Manufacturing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Custom Plasmid Production and Manufacturing Sales Value (2021-2032)
  16. 6.6.2 South America Custom Plasmid Production and Manufacturing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Custom Plasmid Production and Manufacturing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Custom Plasmid Production and Manufacturing Sales Value Share by Country, 2025 VS 2032
7 Custom Plasmid Production and Manufacturing Country-level Value Analysis
  1. 7.1 Global Custom Plasmid Production and Manufacturing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Custom Plasmid Production and Manufacturing Sales Value by Country (2021-2032)
  3. 7.2.1 Global Custom Plasmid Production and Manufacturing Sales Value by Country (2021-2026)
  4. 7.2.2 Global Custom Plasmid Production and Manufacturing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Custom Plasmid Production and Manufacturing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Custom Plasmid Production and Manufacturing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Custom Plasmid Production and Manufacturing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Custom Plasmid Production and Manufacturing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Custom Plasmid Production and Manufacturing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Custom Plasmid Production and Manufacturing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Custom Plasmid Production and Manufacturing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Custom Plasmid Production and Manufacturing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Custom Plasmid Production and Manufacturing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Custom Plasmid Production and Manufacturing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Custom Plasmid Production and Manufacturing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Custom Plasmid Production and Manufacturing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Custom Plasmid Production and Manufacturing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Custom Plasmid Production and Manufacturing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Custom Plasmid Production and Manufacturing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Custom Plasmid Production and Manufacturing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Custom Plasmid Production and Manufacturing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Custom Plasmid Production and Manufacturing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Custom Plasmid Production and Manufacturing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Custom Plasmid Production and Manufacturing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Custom Plasmid Production and Manufacturing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Custom Plasmid Production and Manufacturing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Custom Plasmid Production and Manufacturing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Custom Plasmid Production and Manufacturing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Custom Plasmid Production and Manufacturing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Custom Plasmid Production and Manufacturing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Custom Plasmid Production and Manufacturing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Custom Plasmid Production and Manufacturing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Custom Plasmid Production and Manufacturing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Custom Plasmid Production and Manufacturing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Custom Plasmid Production and Manufacturing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Custom Plasmid Production and Manufacturing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Custom Plasmid Production and Manufacturing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Custom Plasmid Production and Manufacturing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Custom Plasmid Production and Manufacturing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Custom Plasmid Production and Manufacturing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Custom Plasmid Production and Manufacturing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Custom Plasmid Production and Manufacturing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Custom Plasmid Production and Manufacturing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Custom Plasmid Production and Manufacturing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Custom Plasmid Production and Manufacturing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Custom Plasmid Production and Manufacturing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Custom Plasmid Production and Manufacturing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Custom Plasmid Production and Manufacturing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Custom Plasmid Production and Manufacturing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Custom Plasmid Production and Manufacturing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Custom Plasmid Production and Manufacturing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Custom Plasmid Production and Manufacturing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Custom Plasmid Production and Manufacturing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Custom Plasmid Production and Manufacturing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Custom Plasmid Production and Manufacturing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Custom Plasmid Production and Manufacturing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Custom Plasmid Production and Manufacturing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Custom Plasmid Production and Manufacturing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Custom Plasmid Production and Manufacturing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Custom Plasmid Production and Manufacturing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Custom Plasmid Production and Manufacturing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Custom Plasmid Production and Manufacturing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Custom Plasmid Production and Manufacturing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Custom Plasmid Production and Manufacturing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Custom Plasmid Production and Manufacturing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Custom Plasmid Production and Manufacturing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Custom Plasmid Production and Manufacturing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Custom Plasmid Production and Manufacturing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Custom Plasmid Production and Manufacturing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Custom Plasmid Production and Manufacturing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Custom Plasmid Production and Manufacturing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Custom Plasmid Production and Manufacturing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Custom Plasmid Production and Manufacturing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Custom Plasmid Production and Manufacturing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Custom Plasmid Production and Manufacturing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Custom Plasmid Production and Manufacturing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Custom Plasmid Production and Manufacturing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Custom Plasmid Production and Manufacturing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Custom Plasmid Production and Manufacturing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Custom Plasmid Production and Manufacturing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Custom Plasmid Production and Manufacturing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Custom Plasmid Production and Manufacturing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Custom Plasmid Production and Manufacturing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Custom Plasmid Production and Manufacturing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Custom Plasmid Production and Manufacturing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Custom Plasmid Production and Manufacturing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Custom Plasmid Production and Manufacturing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Custom Plasmid Production and Manufacturing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Aldevron
  2. 8.1.1 Aldevron Company Information
  3. 8.1.2 Aldevron Business Overview
  4. 8.1.3 Aldevron Custom Plasmid Production and Manufacturing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Aldevron Custom Plasmid Production and Manufacturing Product Portfolio
  6. 8.1.5 Aldevron Recent Developments
  7. 8.2 Catalent Biologics
  8. 8.2.1 Catalent Biologics Company Information
  9. 8.2.2 Catalent Biologics Business Overview
  10. 8.2.3 Catalent Biologics Custom Plasmid Production and Manufacturing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Catalent Biologics Custom Plasmid Production and Manufacturing Product Portfolio
  12. 8.2.5 Catalent Biologics Recent Developments
  13. 8.3 Polyplus
  14. 8.3.1 Polyplus Company Information
  15. 8.3.2 Polyplus Business Overview
  16. 8.3.3 Polyplus Custom Plasmid Production and Manufacturing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Polyplus Custom Plasmid Production and Manufacturing Product Portfolio
  18. 8.3.5 Polyplus Recent Developments
  19. 8.4 Creative Biogene
  20. 8.4.1 Creative Biogene Company Information
  21. 8.4.2 Creative Biogene Business Overview
  22. 8.4.3 Creative Biogene Custom Plasmid Production and Manufacturing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Creative Biogene Custom Plasmid Production and Manufacturing Product Portfolio
  24. 8.4.5 Creative Biogene Recent Developments
  25. 8.5 PlasmidFactory GmbH
  26. 8.5.1 PlasmidFactory GmbH Company Information
  27. 8.5.2 PlasmidFactory GmbH Business Overview
  28. 8.5.3 PlasmidFactory GmbH Custom Plasmid Production and Manufacturing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 PlasmidFactory GmbH Custom Plasmid Production and Manufacturing Product Portfolio
  30. 8.5.5 PlasmidFactory GmbH Recent Developments
  31. 8.6 Bionexus
  32. 8.6.1 Bionexus Company Information
  33. 8.6.2 Bionexus Business Overview
  34. 8.6.3 Bionexus Custom Plasmid Production and Manufacturing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Bionexus Custom Plasmid Production and Manufacturing Product Portfolio
  36. 8.6.5 Bionexus Recent Developments
  37. 8.7 Wuxi Advanced Therapies
  38. 8.7.1 Wuxi Advanced Therapies Company Information
  39. 8.7.2 Wuxi Advanced Therapies Business Overview
  40. 8.7.3 Wuxi Advanced Therapies Custom Plasmid Production and Manufacturing Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Wuxi Advanced Therapies Custom Plasmid Production and Manufacturing Product Portfolio
  42. 8.7.5 Wuxi Advanced Therapies Recent Developments
  43. 8.8 Charles River Laboratories
  44. 8.8.1 Charles River Laboratories Company Information
  45. 8.8.2 Charles River Laboratories Business Overview
  46. 8.8.3 Charles River Laboratories Custom Plasmid Production and Manufacturing Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Charles River Laboratories Custom Plasmid Production and Manufacturing Product Portfolio
  48. 8.8.5 Charles River Laboratories Recent Developments
  49. 8.9 Plasmid Biosciences
  50. 8.9.1 Plasmid Biosciences Company Information
  51. 8.9.2 Plasmid Biosciences Business Overview
  52. 8.9.3 Plasmid Biosciences Custom Plasmid Production and Manufacturing Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Plasmid Biosciences Custom Plasmid Production and Manufacturing Product Portfolio
  54. 8.9.5 Plasmid Biosciences Recent Developments
  55. 8.10 Sartorius AG
  56. 8.10.1 Sartorius AG Company Information
  57. 8.10.2 Sartorius AG Business Overview
  58. 8.10.3 Sartorius AG Custom Plasmid Production and Manufacturing Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Sartorius AG Custom Plasmid Production and Manufacturing Product Portfolio
  60. 8.10.5 Sartorius AG Recent Developments
  61. 8.11 Porton Advanced
  62. 8.11.1 Porton Advanced Company Information
  63. 8.11.2 Porton Advanced Business Overview
  64. 8.11.3 Porton Advanced Custom Plasmid Production and Manufacturing Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Porton Advanced Custom Plasmid Production and Manufacturing Product Portfolio
  66. 8.11.5 Porton Advanced Recent Developments
  67. 8.12 Oxford Genetics LTD
  68. 8.12.1 Oxford Genetics LTD Company Information
  69. 8.12.2 Oxford Genetics LTD Business Overview
  70. 8.12.3 Oxford Genetics LTD Custom Plasmid Production and Manufacturing Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Oxford Genetics LTD Custom Plasmid Production and Manufacturing Product Portfolio
  72. 8.12.5 Oxford Genetics LTD Recent Developments
  73. 8.13 uBriGene
  74. 8.13.1 uBriGene Company Information
  75. 8.13.2 uBriGene Business Overview
  76. 8.13.3 uBriGene Custom Plasmid Production and Manufacturing Revenue and Gross Margin (2021-2026)
  77. 8.13.4 uBriGene Custom Plasmid Production and Manufacturing Product Portfolio
  78. 8.13.5 uBriGene Recent Developments
  79. 8.14 TriLink BioTechnologies
  80. 8.14.1 TriLink BioTechnologies Company Information
  81. 8.14.2 TriLink BioTechnologies Business Overview
  82. 8.14.3 TriLink BioTechnologies Custom Plasmid Production and Manufacturing Revenue and Gross Margin (2021-2026)
  83. 8.14.4 TriLink BioTechnologies Custom Plasmid Production and Manufacturing Product Portfolio
  84. 8.14.5 TriLink BioTechnologies Recent Developments
  85. 8.15 Vectorbuilder
  86. 8.15.1 Vectorbuilder Company Information
  87. 8.15.2 Vectorbuilder Business Overview
  88. 8.15.3 Vectorbuilder Custom Plasmid Production and Manufacturing Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Vectorbuilder Custom Plasmid Production and Manufacturing Product Portfolio
  90. 8.15.5 Vectorbuilder Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst